[HTML][HTML] lncRNA PVT1 in the pathogenesis and clinical management of renal cell carcinoma
J Bohosova, A Kubickova, O Slaby - Biomolecules, 2021 - mdpi.com
LncRNA PVT1 (plasmacytoma variant translocation 1) has become a staple of the lncRNA
profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors …
profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors …
[HTML][HTML] Contemporary clinical definitions, differential diagnosis, and novel predictive tools for renal cell carcinoma
Despite significant progress regarding clinical detection/imaging evaluation modalities and
genetic/molecular characterization of pathogenesis, advanced renal cell carcinoma (RCC) …
genetic/molecular characterization of pathogenesis, advanced renal cell carcinoma (RCC) …
[HTML][HTML] Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
B Franczyk, J Rysz, J Ławiński, A Ciałkowska-Rysz… - Biomedicines, 2023 - mdpi.com
Renal cell carcinoma (RCC) is one of the most frequent malignant neoplasms of the kidney.
The therapeutic options available for the treatment of advanced or metastatic RCC include …
The therapeutic options available for the treatment of advanced or metastatic RCC include …
Heterogeneity of platelet derived growth factor pathway gene expression profile defines three distinct subgroups of renal cell carcinomas
AM Ferician, OC Ferician, AD Cumpanas… - Cancer Genomics & …, 2022 - cgp.iiarjournals.org
Background/Aim: We previously described four different vascular patterns (reticular, diffuse,
fasciculate, and trabecular) in renal cell carcinoma (RCC) suggesting an early and …
fasciculate, and trabecular) in renal cell carcinoma (RCC) suggesting an early and …
[HTML][HTML] Precision medicine: an optimal approach to patient care in renal cell carcinoma
R Sharma, G Kannourakis, P Prithviraj… - Frontiers in Medicine, 2022 - frontiersin.org
Renal cell cancer (RCC) is a heterogeneous tumor that shows both intra-and inter-
heterogeneity. Heterogeneity is displayed not only in different patients but also among RCC …
heterogeneity. Heterogeneity is displayed not only in different patients but also among RCC …
[HTML][HTML] Macrophage phenotype in combination with tumor microbiome composition predicts RCC patients' survival: a pilot study
OV Kovaleva, P Podlesnaya, M Sorokin… - Biomedicines, 2022 - mdpi.com
The identification of new prognostic markers of renal cell carcinoma (RCC) is an urgent
problem in oncourology. To investigate the potential prognostic significance of tumor …
problem in oncourology. To investigate the potential prognostic significance of tumor …
[HTML][HTML] Renal cell carcinoma in end-stage renal disease: A retrospective study in patients from Hungary
D Semjén, B Dénes, Á Somorácz, A Fintha, G Forika… - Pathobiology, 2023 - karger.com
Introduction: End-stage renal disease (ESRD) and acquired cystic kidney disease (ACKD)
are known risk factors for renal cell carcinoma (RCC). Hereby, the clinicopathological …
are known risk factors for renal cell carcinoma (RCC). Hereby, the clinicopathological …
Circular RNA Eps15-homology domain-containing protein 2 induce resistance of renal cell carcinoma to sunitinib via microRNA-4731-5p/ABCF2 axis
W Li, GX Li, LQ Cao - Bioengineered, 2022 - Taylor & Francis
Circular RNAs (circRNAs) are linked with the occurrence and progression of renal cell
carcinoma (RCC). However, circRNAs' mechanism in developing resistance to RCC has not …
carcinoma (RCC). However, circRNAs' mechanism in developing resistance to RCC has not …
[HTML][HTML] Malignant glomus tumor of prostate: A case report
Z Sun, F Sun, C Yu, H Xiao, Q Xu, B Gao, L Guo… - Frontiers in …, 2023 - frontiersin.org
We reported an 85-year-old patient with malignant glomus tumor (GT) of the prostate. He
presented with urinary frequency for more than 2 years and gross hematuria for 7 days …
presented with urinary frequency for more than 2 years and gross hematuria for 7 days …
[HTML][HTML] Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities
Simple Summary The latest World Health Organization classification for kidney tumors,
released in 2022, brings important changes, introducing new types of tumors and refining …
released in 2022, brings important changes, introducing new types of tumors and refining …